UNITED STATES OF AMERICA : The United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its potential coronavirus vaccine, as it stocks up on vaccine and drugs in an attempt to tame the pandemic.The latest contract is priced at roughly $10 per vaccine dose produced by J&J, or around $14.50 per dose, including a previous $456 million the US government promised to J&J for vaccine development in March.
That compares with the $19.50 per dose that the US is paying for the vaccine being developed by Pfizer Inc and German biotech BioNTech SE.J&J is studying both one and two-dose regimens of its vaccine.